🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa › New York › New York City

Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa New York City, NY keessatti

Qorannoo 10 Leukemia Biphenotypicii Hamaa f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Namoota walitti qabaa jiraSadarkaa 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • NYP/Weill Cornell Medical Center, New York
365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Namoota walitti qabaa jiraSadarkaa 1/2
  • Montefiore Medical Center, New York
30 Days · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Namoota walitti qabaa jiraSadarkaa 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Mount Sinai Hospital, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • fi 2 dabalataa
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan- Kettering Cancer Center, New York
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06177067

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 2
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443

A Study of Revumenib and Mezigdomide in People With Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07356154

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 08-Ama-2026 · NCT04872478

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Children's Hospital New York-Presbyterian, New York
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Qorannoo Leukemia Biphenotypicii Hamaa magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.